Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) 1,2,4 Butanetriol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108620103B reveals a novel solid acid catalyst enabling high-yield, optically pure synthesis of this critical pharmaceutical intermediate via direct dehydration.
Patent CN112941114A reveals high-purity enzymatic route for chiral triols. Reduces production cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing.